AstraZeneca advances haematology and cell therapy ambition with largest-ever presence at ASH: Cambridge, UK Friday, December 5, 2025, 10:00 Hrs [IST] AstraZeneca, a global, scienc ...
Hospitals around the world are bracing for a future where common infections no longer respond to standard drugs. Among the ...
Explore West Palm Beach’s essential bucket-list experiences, from waterfront views and arts to cultural landmarks and hidden ...
Simultaneously measuring levels of two blood proteins may help monitor both disease activity and disability progression in ...
Evercore 8th Annual Healthcare Conference December 3, 2025 10:00 AM ESTCompany ParticipantsPeter Griffith - Executive VP & ...
This represents one of JTCC's largest and most diverse scientific contributions to ASH to date, highlighting innovations in cell therapy, targeted agents, AI-driven diagnostics, stem cell ...
Every school had a certified genius. They were the valedictorian, the kid who ruined the grading curve, the person whose future seemed like a straight, golden road paved with scholarships and success.
RWJBarnabas Health's commitment to enhancing access to care includes a transformative partnership with Rutgers University, including the Rutgers Cancer Institute -- the state's only NCI-designated ...
New approaches hurdle biological barriers to attack recalcitrant targets to tackle difficult-to-treat and recurrent cancers.
Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...
Objective response rate (ORR) of 83% including two complete responses in CLL patients in Phase 1a study with median progression free survival ...
This story was commissioned by the River City Journalism Fund Mary Eagan, 71, stares at the body-height punching bag, her delicate hands buried in a pair of giant red boxing gloves. On this warm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results